TIBER CREEK GROUP for AMGEN INC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
H.R. 5376 - Build Back Better Act, Subtitle J; Issues relating to Part D pricing reform; Issues relating to Part B pricing reform; Issues related to capping out-of-pocket costs; Issues related to the Self Administered Drug Exclusion List; Issues related to payments for ESRD services under Medicare; Issues related to Medicare Part D drug rebates; S. 1943 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021; Issues related to proposed national coverage decision (NCD) for Medicare beneficiaries with Alzheimer's.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| COREY MALMGREN | — |
Health Issues HCR
S. 4348 - Food and Drug Administration Safety and Landmark Advancements Act of 2022; HR 7667 - Food and Drug Amendments of 2022; Issues related to treatment challenges for cardiovascular disease.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| COREY MALMGREN | — |
Communications/Broadcasting/Radio/TV COM
Issues related to Direct to Consumer Advertising.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHON JONES | — |
| COREY MALMGREN | — |
| TIMOTHY A MOLINO New | Counsel, Sen. Judiciary Cmte. (2010-2011); Counsel, Sen. Amy Klobuchar (2010) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.